Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

July 5, 2018

Similar Symptoms of Gaucher and Primary Myelofibrosis Can Result in Misdiagnosis, Case Report Shows

News

The similar clinical and laboratory features of primary myelofibrosis (PMF) — a disease of the liver, blood, and bone marrow — and Gaucher disease may sometimes result in a misdiagnosis of the ... Read more

March 1, 2018March 1, 2018

Newly identified Player in Gaucher Disease Could be Helpful in Diagnosis, Monitoring, Study Says

News

A new protein recently identified by researchers could be used in diagnosing patients with Gaucher disease or assessing how patients are responding to therapies, a study suggests. Chitinase-3-like 1 (CHI3L1), ... Read more

January 23, 2018

Brazilian Researchers Establish Nursing Diagnosis Guidelines for Gaucher Disease

News

Researchers in Brazil identified a set of signs and symptoms of Gaucher disease to help establish a priority nursing diagnosis for the disease. This allows nurses to distinguish the rare ... Read more

August 22, 2017

Gaucher Patients Have Mixed Views About Substrate Reduction Therapies, Study Finds

News

People with Gaucher’s disease have mixed views about using oral substrate reduction therapies as an alternative to enzyme replacement therapies, a study reports. Some favor substrate reduction therapies, or SRTs, ... Read more

April 20, 2017April 20, 2017

Doctors Use Fluid Collected from Infant’s Lungs to Confirm Perinatal Lethal Gaucher Disease

News

Japanese researchers analyzed brochoalveolar lavage fluid (BALF) collected from the lungs to confirm a diagnosis of perinatal lethal Gaucher disease (PLGD) in an infant who was barely two months old — ... Read more

March 23, 2017

New Model Developed for Predicting Long-Term Complications in Type 1 Gaucher’s

News

A new model for predicting the risk of long-term complications in patients with type 1 Gaucher disease (GD) was designed based on a 17-year study that measured a naturally-occurring enzyme ... Read more

February 27, 2017

Lost Function in Gaucher Cells Partially Restored by Coenzyme Q10, Researchers Say

News

Coenzyme Q10 (CoQ), a naturally occurring antioxidant, partially restored the function of a cell model of Gaucher disease. These artificially produced cells can be used in the future to study the ... Read more

February 16, 2017

Cerdelga Pills as Maintenance for Gaucher Patients as Effective as Injectable Cerezyme, Phase 3 Trial Finds

News

Cerdelga (eliglustat) pills are as effective and safe as the injectable drug Cerezyme (imiglucerase) as a maintenance therapy for Gaucher disease after stabilizing patients on Cerezyme, according to the Phase ... Read more